As of 2025-07-04, the Relative Valuation of Aclaris Therapeutics Inc (ACRS) is (22.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.45 USD, the upside of Aclaris Therapeutics Inc based on Relative Valuation is -1640.5%.
The range of the Relative Valuation is (21.48) - (22.15) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 17.6x - 18.4x | 18.1x |
Forward P/E multiples | 17.9x - 20.5x | 19.0x |
Fair Price | (21.48) - (22.15) | (22.34) |
Upside | -1581.2% - -1627.6% | -1640.5% |
Date | P/E |
2025-07-02 | -1.21 |
2025-07-01 | -1.17 |
2025-06-30 | -1.18 |
2025-06-27 | -1.22 |
2025-06-26 | -1.30 |
2025-06-25 | -1.36 |
2025-06-24 | -1.26 |
2025-06-23 | -1.16 |
2025-06-20 | -1.21 |
2025-06-18 | -1.18 |
2025-06-17 | -1.16 |
2025-06-16 | -1.20 |
2025-06-13 | -1.22 |
2025-06-12 | -1.27 |
2025-06-11 | -1.31 |
2025-06-10 | -1.26 |
2025-06-09 | -1.24 |
2025-06-06 | -1.27 |
2025-06-05 | -1.30 |
2025-06-04 | -1.34 |
2025-06-03 | -1.22 |
2025-06-02 | -1.20 |
2025-05-30 | -1.21 |
2025-05-29 | -1.21 |
2025-05-28 | -1.17 |
2025-05-27 | -1.06 |
2025-05-23 | -1.05 |
2025-05-22 | -1.05 |
2025-05-21 | -1.07 |
2025-05-20 | -1.12 |
2025-05-19 | -1.08 |
2025-05-16 | -1.09 |
2025-05-15 | -1.01 |
2025-05-14 | -0.98 |
2025-05-13 | -1.01 |
2025-05-12 | -1.04 |
2025-05-09 | -1.05 |
2025-05-08 | -1.09 |
2025-05-07 | -1.04 |
2025-05-06 | -1.06 |
2025-05-05 | -1.06 |
2025-05-02 | -1.20 |
2025-05-01 | -1.15 |
2025-04-30 | -1.15 |
2025-04-29 | -1.11 |
2025-04-28 | -1.13 |
2025-04-25 | -1.11 |
2025-04-24 | -1.06 |
2025-04-23 | -0.99 |
2025-04-22 | -0.91 |